
Amgen opens new technology and innovation center in Hyderabad
Hyderabad, March 1, 2025: Global biotech firm Amgen inaugurated its technology and innovation center in Hyderabad, a facility that will help the U.S. based firm ramp up digital capabilities, open more opportunities for the talent pool of the region and build on the city’s position as an emerging hub for global capability centers (GCC).
The company has already hired 300 people for the Hyderabad center, plans to onboard an additional 300 soon while pursuing a goal of having a headcount of 2,000+ by this year, The Hindu reported. The Amgen India facility is spread across 5,24,000 square feet.
Inaugurating the facility, Telangana Chief Minister A. Revanth Reddy on Monday (February 24, 2025) said that opening of the facility is coming together of two global leaders – Amgen and Hyderabad.
The firm has selected Hyderabad for setting up the hub of innovation to tap into the world class talent available in Telangana as well on account of Hyderabad being a pioneer in pharma and life sciences sectors.
Robert A. Bradway, chairman of Amgen said the firm has been wanting to expand to India for sometime. Appreciating Hyderabad for the innovation work it hosts and supporting an enabling ecosystem, he said the company will be investing $200 million by this year and plans to make additional investment in future.
“The opening of Amgen India marks a significant milestone in our endeavour to leverage technology across our global network to better serve patients. “We are grateful to the Government of Telangana for its partnership and are proud to join an ecosystem where life sciences and cutting-edge innovation can thrive,” said Bradway.
The new center is located in HITEC City, occupying approximately 524,000 square feet in RMZ Tower 110 of Spire and Tower 20 of Nexity. Robert A. Bradway, chairman and chief executive officer at Amgen, was joined by Telangana chief minister Anumula Revanth Reddy, minister of IT, electronics & communications, industries & commerce, and legislative affairs D. Sridhar Babu.
“I welcome Amgen to our vibrant city, as they work toward making a difference in patients’ lives around the world. We look forward to working with global leaders such as Amgen to strengthen Hyderabad’s position as a biotech hub,” said Telangana Chief Minister Revanth Reddy.
Under the leadership of the global organization, Amgen India will play a pivotal role in advancing innovation by developing and deploying technology and life sciences solutions to accelerate Amgen’s digital capabilities worldwide.
“Amgen India is a reflection of our growth ambitions as well as an extension of our commitment to global health. We are excited to contribute to the dynamic global biotech ecosystem from India and welcome the incredible talent pool the country offers, said Som Chattopadhyay, national executive for India at Amgen.
Naveen Gullapalli, managing director, Amgen India, emphasized the strategic value of the new site for the company’s global operations, stating: “Hyderabad is rapidly emerging as a global technology hub, and our new site is positioned at the heart of this landscape. Talent at Amgen India will drive global projects and initiatives, leveraging expertise across our global sites. Amgen India employees will bring bold, innovative thinking to help shape the future of global biotechnology from India.”
“With global leaders like Amgen choosing to invest here, we are poised to further enhance our capabilities, foster new opportunities, and set the stage for breakthrough innovations in both biotech and technology,” said Minister Sridhar Babu.
Amgen was founded in 1980 and employs 28,000 people across 100 countries.